Patents by Inventor Michael McCawley

Michael McCawley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240023826
    Abstract: An aerosol spirometer and a method of operating an aerosol spirometer. Comparison of lung function data that has been acquired by the aerosol spirometer to a known, idealized exhalation aerosol concentration profile of healthy lung operation may be used to fill in missing lung function data that arises out of resistance-based and compliance-based inhomogeneities in both aerosol penetration and aerosol deposition, where the inhomogeneities may be mathematically correlated to time constant data that in turn may be directly correlated to ventilation. This data, when added to the idealized exhalation aerosol concentration profile, produces a more complete data-informed exhalation aerosol concentration profile from which an inference may be made about possible lung dysfunction of an individual using the aerosol spirometer. A machine learning model may be trained on the lung function data to provide a predictive inference related to either an onset or worsening of the lung dysfunction.
    Type: Application
    Filed: July 20, 2023
    Publication date: January 25, 2024
    Inventor: Michael McCawley
  • Patent number: 11689482
    Abstract: A computer-implemented method, system and computer program product for dynamically providing a typing feedback indicator. Text entered in a body of a message that is to be sent to a recipient is detected. Prior to the user (author) sending the message to the recipient, the text of the message being composed by the user is analyzed to determine a sentiment and an emotion as well as to determine a topic of the content of the text. Based on such analyses, as well as possibly based on other criteria, a typing feedback indicator is generated to reflect an indication of the content of the message to be sent to the recipient. The typing feedback indicator may then be displayed on a computing device of the recipient while the user (author) is composing the message thereby providing the recipient context awareness of the message prior to receipt of such a message.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: June 27, 2023
    Assignee: International Business Machines Corporation
    Inventors: Nicholas Tsang, Michael McCawley, Dong Zhang, Haoyang Li
  • Publication number: 20230147542
    Abstract: A computer-implemented method, system and computer program product for dynamically providing a typing feedback indicator. Text entered in a body of a message that is to be sent to a recipient is detected. Prior to the user (author) sending the message to the recipient, the text of the message being composed by the user is analyzed to determine a sentiment and an emotion as well as to determine a topic of the content of the text. Based on such analyses, as well as possibly based on other criteria, a typing feedback indicator is generated to reflect an indication of the content of the message to be sent to the recipient. The typing feedback indicator may then be displayed on a computing device of the recipient while the user (author) is composing the message thereby providing the recipient context awareness of the message prior to receipt of such a message.
    Type: Application
    Filed: November 10, 2021
    Publication date: May 11, 2023
    Inventors: Nicholas Tsang, Michael McCawley, Dong Zhang, Haoyang Li
  • Patent number: 11645138
    Abstract: The exemplary embodiments disclose a system and method, a computer program product, and a computer system for diagnosing technical issues. The exemplary embodiments may include collecting data relating to one or more technical issues, extracting one or more features from the collected data, determining one or more diagnoses based on the extracted one or more features and one or more models, and suggesting to a support agent one or more actions based on the one or more determined diagnoses.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: May 9, 2023
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Michael McCawley, Robert E. Loredo, Lily Ryzebol
  • Patent number: 11443216
    Abstract: A system, computer program product, and method are provided to conduct gap probability mapping to predict presence and location of one or more gaps in a corpus. A probabilistic model is formed to represent inter-corpora associations of objects, which the model leverages to process query submissions. As queries are received and processed, the model creates an adjustment. Subject to evaluation, confidence of the adjustment is evaluated, and a response correlated to the confidence is returned.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: September 13, 2022
    Assignee: International Business Machines Corporation
    Inventors: Michael McCawley, Adriana Valido, Robert E. Loredo
  • Publication number: 20220004479
    Abstract: The exemplary embodiments disclose a system and method, a computer program product, and a computer system for diagnosing technical issues. The exemplary embodiments may include collecting data relating to one or more technical issues, extracting one or more features from the collected data, determining one or more diagnoses based on the extracted one or more features and one or more models, and suggesting to a support agent one or more actions based on the one or more determined diagnoses.
    Type: Application
    Filed: July 1, 2020
    Publication date: January 6, 2022
    Inventors: Michael McCawley, Robert E. Loredo, Lily Ryzebol
  • Publication number: 20200242494
    Abstract: A system, computer program product, and method are provided to conduct gap probability mapping to predict presence and location of one or more gaps in a corpus. A probabilistic model is formed to represent inter-corpora associations of objects, with the model leverages to process query submissions. As queries are received and processed, the model creates an adjustment. Subject to evaluation, confidence of the adjustment is evaluated, and a response correlated to the confidence is returned.
    Type: Application
    Filed: January 30, 2019
    Publication date: July 30, 2020
    Applicant: International Business Machines Corporation
    Inventors: Michael McCawley, Adriana Valido, Robert E. Loredo
  • Patent number: 8353845
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: January 15, 2013
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Gasner, Ian Christie, Tal Gottesman, James Dalton
  • Publication number: 20110247611
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Application
    Filed: June 16, 2011
    Publication date: October 13, 2011
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Ganser, Ian Christie, Tal Gottesman, James Dalton
  • Patent number: 7988641
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: August 2, 2011
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Gasner, Ian Christie, Tal Gottesman, James Dalton
  • Patent number: 7880878
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Grant
    Filed: June 14, 2010
    Date of Patent: February 1, 2011
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, Bernard McGee
  • Publication number: 20100253944
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Application
    Filed: June 14, 2010
    Publication date: October 7, 2010
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, B. J. McGee
  • Publication number: 20100222692
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Application
    Filed: April 30, 2010
    Publication date: September 2, 2010
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Gasner, Ian Christie, Tal Gottesman, James Dalton
  • Patent number: 7738100
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: June 15, 2010
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, Bernard McGee
  • Patent number: 7732749
    Abstract: A system for measuring the output of a photodetector is disclosed. An integrating amplifier circuit receives a signal output from the photodetector and is adapted to output an integrating amplifier voltage proportional to the signal output from the photodetector. A reference source is adapted to serve as a voltage source and is adapted to output a reference voltage proportional to background light incident upon the photodetector. A difference amplifier electronically coupled to the integrating amplifier circuit and to the adjustable reference, receiving the integrating amplifier voltage and the reference voltage, respectively. The difference amplifier is adapted to generate an amplified output using the reference voltage subtracted from the integrating amplifier voltage.
    Type: Grant
    Filed: February 28, 2008
    Date of Patent: June 8, 2010
    Assignee: Respiratory Management Technology
    Inventor: Michael McCawley
  • Patent number: 7731666
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: June 8, 2010
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Ganser, Ian Christie, Tal Gottesman, James Dalton
  • Publication number: 20090219091
    Abstract: A system for measuring the output of a photodetector is disclosed. An integrating amplifier circuit receives a signal output from the photodetector and is adapted to output an integrating amplifier voltage proportional to the signal output from the photodetector. A reference source is adapted to serve as a voltage source and is adapted to output a reference voltage proportional to background light incident upon the photodetector. A difference amplifier electronically coupled to the integrating amplifier circuit and to the adjustable reference, receiving the integrating amplifier voltage and the reference voltage, respectively. The difference amplifier is adapted to generate an amplified output using the reference voltage subtracted from the integrating amplifier voltage.
    Type: Application
    Filed: February 28, 2008
    Publication date: September 3, 2009
    Inventor: Michael McCawley
  • Publication number: 20090168051
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Application
    Filed: July 21, 2006
    Publication date: July 2, 2009
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, B. J. McGee
  • Publication number: 20080015456
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Application
    Filed: June 29, 2007
    Publication date: January 17, 2008
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Ganser, Ian Christie, Tal Gottesman, James Dalton
  • Patent number: 7241269
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Grant
    Filed: September 2, 2003
    Date of Patent: July 10, 2007
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Ganser, Ian Christie, Tal Gottesman, James Dalton